Suchergebnisse - "Chau, Ian"

PubPharm (448)

1

Binimetinib in combination with nivolumab or nivolumab and ipilimumab in patients with previously treated microsatellite-stable metastatic colorectal cancer with RAS mutations in an open-label phase 1b/2 study

enthalten in: BMC cancer | 2024

von Elez, E. | Cubillo, A. | Alfonso, P. | +6

2

Binimetinib in combination with nivolumab or nivolumab and ipilimumab in patients with previously treated microsatellite-stable metastatic colorectal cancer with RAS mutations in an open-label phase 1b/2 study

enthalten in: BMC cancer | 2024

von Elez, E. | Cubillo, A. | Alfonso, P. | +6

3

Clinical practice guidelines for esophagogastric junction cancer : Upper GI Oncology Summit 2023

enthalten in: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association | 2024

von Kitagawa, Y. | Matsuda, S. | Gotoda, T. | +60

4

Early switch from intravenous to oral antibiotic therapy in patients with cancer who have low-risk neutropenic sepsis : the EASI-SWITCH RCT

enthalten in: Health technology assessment (Winchester, England) | 2024

von Coyle, V. | Forde, C. | Adams, R. | +14

5

Rivoceranib, a VEGFR-2 inhibitor, monotherapy in previously treated patients with advanced or metastatic gastric or gastroesophageal junction cancer (ANGEL study) : an international, randomized, placebo-controlled, phase 3 trial

enthalten in: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association | 2024

von Kang, Y. | Ryu, M. | Di Bartolomeo, M. | +15

6

Clinical practice guidelines for esophagogastric junction cancer: Upper GI Oncology Summit 2023

enthalten in: Gastric cancer | 2024

von Kitagawa, Y. | Matsuda, S. | Gotoda, T. | +60

7

Circulating microRNA analysis in a prospective co-clinical trial identifies MIR652-3p as a response biomarker and driver of regorafenib resistance mechanisms in colorectal cancer

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Hedayat, S. | Cascione, L. | Cunningham, D. | +43

8

Genetic and immune landscape evolution in MMR-deficient colorectal cancer

enthalten in: The Journal of pathology | 2024

von Challoner, B. | Woolston, A. | Lau, D. | +38

9

Early switch to oral antibiotic therapy in patients with low-risk neutropenic sepsis (EASI-SWITCH) : a randomized non-inferiority trial

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2024

von Coyle, V. | Forde, C. | McAuley, D. | +14

10

Rivoceranib, a VEGFR-2 inhibitor, monotherapy in previously treated patients with advanced or metastatic gastric or gastroesophageal junction cancer (ANGEL study): an international, randomized, placebo-controlled, phase 3 trial

enthalten in: Gastric Cancer | 2024

von Kang, Y. | Ryu, M. | Di Bartolomeo, M. | +15

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[45]